HealthMedicine
The Black Market for Retatrutide, the Super-Ozempic
Demand for Eli Lilly's unapproved weight-loss drug retatrutide has spawned a thriving black market. At least 14 hospitalizations linked to its use.
—4 min read
Tag
#Glp 1
3 articles
HealthScience
GLP-1 Drugs May Protect Against Cancer, Studies Suggest
New research at ASCO 2026 suggests GLP-1 drugs like Ozempic and Wegovy may reduce cancer risk and slow progression beyond weight loss.
—5 min read
Health & Science
Eli Lilly's Retatrutide Yields 28% Weight Loss in Trial
Eli Lilly's retatrutide led to 28.3% weight loss in a Phase 3 trial, approaching bariatric surgery results. But high side effect rates raise questions.
—5 min read